AEMD Financial Statements

Balance sheet, income statement, cash flow, and dividends for Aethlon Medical Inc (AEMD).


$4.40M Market Cap.

As of 06/27/2024 5:00 PM ET (MRY) • Disclaimer

AEMD Market Cap. (MRY)


AEMD Shares Outstanding (MRY)


AEMD Assets (MRY)


Total Assets

$8.25M

Total Liabilities

$2.48M

Total Investments

$0

AEMD Income (MRY)


Revenue

$0

Net Income

-$12.21M

Operating Expense

$12.64M

AEMD Cash Flow (MRY)


CF Operations

-$10.13M

CF Investing

-$250.87K

CF Financing

$1.29M

AEMD Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

AEMD Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$8,245,982 (-52.90%)

$17,508,940 (-9.83%)

$19,417,954 (82.00%)

$10,668,916 (2.71%)

Assets Current

$6,225,788 (-58.74%)

$15,090,566 (-16.89%)

$18,157,007 (75.40%)

$10,351,738 (3.09%)

Assets Non-Current

$2,020,194 (-16.46%)

$2,418,374 (91.79%)

$1,260,947 (297.55%)

$317,178 (-8.48%)

Goodwill & Intangible Assets

$1,100 (-33.33%)

$1,650 (-25.00%)

$2,200 (-96.14%)

$56,954 (-0.96%)

Shareholders Equity

$5,766,332 (-61.72%)

$15,064,209 (-12.08%)

$17,133,108 (81.68%)

$9,430,604 (0.22%)

Property Plant & Equipment Net

$1,898,283 (-17.32%)

$2,295,913 (101.76%)

$1,137,936 (465.18%)

$201,339 (-27.29%)

Cash & Equivalents

$5,562,789 (-62.04%)

$14,653,754 (-14.77%)

$17,193,230 (73.31%)

$9,920,460 (3.16%)

Accumulated Other Comprehensive Income

-$6,940 (-13.01%)

-$6,141 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$344,547 (200.00%)

$114,849 (14.85%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$127,965 (-14.16%)

$149,082 (-27.89%)

Trade & Non-Trade Payables

$1,324,296 (104.65%)

$647,111 (-1.31%)

$655,704 (43.73%)

$456,198 (14.99%)

Accumulated Retained Earnings (Deficit)

-$154,566,728 (-8.58%)

-$142,358,555 (-9.23%)

-$130,329,181 (-8.69%)

-$119,913,090 (-7.04%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$649,751 (-30.85%)

$939,642 (55.96%)

$602,505 (0%)

$0 (0%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$649,751 (-30.85%)

$939,642 (55.96%)

$602,505 (0%)

$0 (0%)

Total Liabilities

$2,479,650 (1.43%)

$2,444,731 (0.75%)

$2,426,554 (76.45%)

$1,375,226 (23.87%)

Liabilities Current

$1,829,899 (21.58%)

$1,505,089 (-17.49%)

$1,824,049 (32.64%)

$1,375,226 (28.80%)

Liabilities Non-Current

$649,751 (-30.85%)

$939,642 (55.96%)

$602,505 (0%)

$0 (0%)

AEMD Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$574,245 (95.21%)

$294,165 (-55.37%)

$659,104 (1.37%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$3,903,191 (-12.90%)

$4,481,303 (29.70%)

$3,455,222 (40.57%)

$2,457,998 (58.73%)

Research & Development Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Expenses

$12,636,568 (1.31%)

$12,472,883 (16.41%)

$10,715,050 (25.31%)

$8,550,603 (29.94%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$12,208,174 (-1.48%)

-$12,029,786 (-15.44%)

-$10,420,885 (-32.05%)

-$7,891,499 (-23.69%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

-$4,794 (-0.08%)

-$4,790 (21.39%)

Net Income

-$12,208,174 (-1.48%)

-$12,029,786 (-15.49%)

-$10,416,091 (-32.07%)

-$7,886,709 (-23.73%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$12,208,174 (-1.48%)

-$12,029,786 (-15.49%)

-$10,416,091 (-32.07%)

-$7,886,709 (-23.73%)

Weighted Average Shares

$2,512,774 (22.35%)

$2,053,743 (39.17%)

$1,475,697 (22.05%)

$1,209,088 (254.07%)

Weighted Average Shares Diluted

$2,512,774 (22.35%)

$2,053,743 (39.17%)

$1,475,697 (22.05%)

$1,209,088 (254.07%)

Earning Before Interest & Taxes (EBIT)

-$12,208,174 (-1.48%)

-$12,029,786 (-15.49%)

-$10,416,091 (-32.07%)

-$7,886,709 (-24.80%)

Gross Profit

$0 (0%)

$574,245 (95.21%)

$294,165 (-55.37%)

$659,104 (1.37%)

Operating Income

-$12,636,568 (-6.20%)

-$11,898,638 (-14.18%)

-$10,420,885 (-32.05%)

-$7,891,499 (-33.08%)

AEMD Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$250,867 (73.40%)

-$943,109 (-170.08%)

-$349,193 (-483.14%)

-$59,881 (60.52%)

Net Cash Flow from Financing

$1,287,605 (-85.56%)

$8,914,718 (-48.67%)

$17,367,974 (143.65%)

$7,128,342 (-35.93%)

Net Cash Flow from Operations

-$10,129,810 (3.57%)

-$10,505,128 (-7.56%)

-$9,767,157 (-44.38%)

-$6,764,940 (-30.15%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$9,090,965 (-258.83%)

-$2,533,519 (-134.94%)

$7,251,624 (2289.17%)

$303,521 (-94.75%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$250,867 (73.40%)

-$943,109 (-170.08%)

-$349,193 (-483.14%)

-$59,881 (60.52%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$1,322,383 (-85.19%)

$8,927,211 (-48.86%)

$17,456,092 (140.41%)

$7,260,869 (-40.29%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$2,107 (135.37%)

-$5,957 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$1,219,370 (15.92%)

$1,051,898 (40.14%)

$750,621 (-3.70%)

$779,421 (-7.65%)

Depreciation Amortization & Accretion

$359,200 (35.39%)

$265,300 (72.03%)

$154,217 (311.82%)

$37,448 (42.03%)

AEMD Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-

-2094.90% (40.84%)

-3540.90% (-195.91%)

-1196.60% (-22.06%)

EBITDA Margin

-

-2048.70% (41.27%)

-3488.50% (-192.93%)

-1190.90% (-23.04%)

Return on Average Equity (ROAE)

-132.70% (-85.59%)

-71.50% (-47.12%)

-48.60% (22.98%)

-63.10% (63.78%)

Return on Average Assets (ROAA)

-103.20% (-68.08%)

-61.40% (-34.35%)

-45.70% (20.52%)

-57.50% (56.51%)

Return on Sales (ROS)

-

-2094.90% (40.84%)

-3540.90% (-195.91%)

-1196.60% (-23.11%)

Return on Invested Capital (ROIC)

-825.50% (-24.74%)

-661.80% (89.69%)

-6420.10% (-719.40%)

1036.50% (-35.19%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.35 (46.60%)

-0.65 (68.48%)

-2.06 (34.17%)

-3.12 (-284.13%)

Price to Sales Ratio (P/S)

-

13.68 (-81.32%)

73.24 (96.68%)

37.24 (366.48%)

Price to Book Ratio (P/B)

0.76 (30.87%)

0.58 (-55.60%)

1.31 (-49.69%)

2.61 (74.58%)

Debt to Equity Ratio (D/E)

0.43 (165.43%)

0.16 (14.08%)

0.14 (-2.74%)

0.15 (23.73%)

Earnings Per Share (EPS)

-4.86 (17.63%)

-5.9 (16.90%)

-7.1 (-9.23%)

-6.5 (65.24%)

Sales Per Share (SPS)

0 (0%)

0.28 (40.70%)

0.2 (-63.49%)

0.55 (-71.38%)

Free Cash Flow Per Share (FCFPS)

-4.13 (25.89%)

-5.57 (18.69%)

-6.86 (-21.43%)

-5.64 (63.96%)

Book Value Per Share (BVPS)

2.29 (-68.71%)

7.33 (-36.82%)

11.61 (48.85%)

7.8 (-71.69%)

Tangible Assets Book Value Per Share (TABVPS)

3.28 (-61.51%)

8.53 (-35.21%)

13.16 (49.90%)

8.78 (-70.99%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

1 (0%)

0 (0%)

-2 (0.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

0.25 (-62.41%)

0.67 (400.90%)

-0.22 (86.03%)

-1.58 (1.13%)

Asset Turnover

0 (0%)

0.03 (123.08%)

0.01 (-72.92%)

0.05 (-64.44%)

Current Ratio

3.4 (-66.07%)

10.03 (0.72%)

9.95 (32.24%)

7.53 (-19.96%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$10,380,677 (9.33%)

-$11,448,237 (-13.17%)

-$10,116,350 (-48.23%)

-$6,824,821 (-27.58%)

Enterprise Value (EV)

-$2,965,705 (62.10%)

-$7,825,299 (-445.05%)

$2,267,891 (-81.74%)

$12,420,276 (23.38%)

Earnings Before Tax (EBT)

-$12,208,174 (-1.48%)

-$12,029,786 (-15.49%)

-$10,416,091 (-32.07%)

-$7,886,709 (-23.73%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$11,848,974 (-0.72%)

-$11,764,486 (-14.64%)

-$10,261,874 (-30.74%)

-$7,849,261 (-24.72%)

Invested Capital

$1,501,945 (-34.36%)

$2,288,089 (128.58%)

$1,000,980 (246.40%)

-$683,724 (-119.19%)

Working Capital

$4,395,889 (-67.64%)

$13,585,477 (-16.82%)

$16,332,958 (81.95%)

$8,976,512 (0.03%)

Tangible Asset Value

$8,244,882 (-52.91%)

$17,507,290 (-9.83%)

$19,415,754 (82.96%)

$10,611,962 (2.73%)

Market Capitalization

$4,402,270 (-49.89%)

$8,785,776 (-60.95%)

$22,496,017 (-8.59%)

$24,610,754 (74.92%)

Average Equity

$9,201,458 (-45.29%)

$16,818,488 (-21.54%)

$21,436,505 (71.42%)

$12,505,158 (241.72%)

Average Assets

$11,827,907 (-39.66%)

$19,603,214 (-13.90%)

$22,768,854 (66.13%)

$13,705,577 (184.28%)

Invested Capital Average

$1,478,926 (-18.63%)

$1,817,604 (1020.30%)

$162,243 (121.32%)

-$760,868 (-92.55%)

Shares

2,620,399 (14.08%)

2,296,935 (49.07%)

1,540,823 (27.09%)

1,212,352 (30.98%)